Evidence map›Paper›PMID 27313835›Full record

ReviewOxidative medicine and cellular longevity2016

RAGE Expression and ROS Generation in Neurons: Differentiation versus Damage.

S Piras, A L Furfaro, C Domenicotti, N Traverso, U M Marinari, M A Pronzato, M Nitti

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Deciphering the mechanisms by which probioticCurrent research in food science · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Methylglyoxal Formation-Metabolic Routes and Consequences.Antioxidants (Basel, Switzerland) · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

S PirasDepartment of Experimental Medicine, University of Genoa, Via L.B. Alberti 2, 16132 Genoa, Italy.
A L FurfaroGiannina Gaslini Institute, Via Gerolamo Gaslini 5, 16147 Genoa, Italy.
C DomenicottiDepartment of Experimental Medicine, University of Genoa, Via L.B. Alberti 2, 16132 Genoa, Italy.
N TraversoDepartment of Experimental Medicine, University of Genoa, Via L.B. Alberti 2, 16132 Genoa, Italy.
U M MarinariDepartment of Experimental Medicine, University of Genoa, Via L.B. Alberti 2, 16132 Genoa, Italy.
M A PronzatoDepartment of Experimental Medicine, University of Genoa, Via L.B. Alberti 2, 16132 Genoa, Italy.
M NittiDepartment of Experimental Medicine, University of Genoa, Via L.B. Alberti 2, 16132 Genoa, Italy.
University of Genoa · ITIstituto Giannina Gaslini · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RAGE is a multiligand receptor able to bind advanced glycation end-products (AGEs), amphoterin, calgranulins, and amyloid-beta peptides, identified in many tissues and cells, including neurons. RAGE stimulation induces the generation of reactive oxygen species (ROS) mainly through the activity of NADPH oxidases. In neuronal cells, RAGE-induced ROS generation is able to favor cell survival and differentiation or to induce death through the imbalance of redox state. The dual nature of RAGE signaling in neurons depends not only on the intensity of RAGE activation but also on the ability of RAGE-bearing cells to adapt to ROS generation. In this review we highlight these aspects of RAGE signaling regulation in neuronal cells.

Indexed as

AnimalsCell DifferentiationGlycation End Products, AdvancedHumansNADPH OxidasesNeuronsReactive Oxygen SpeciesReceptor for Advanced Glycation End ProductsSignal TransductionGlycation End Products, AdvancedNADPH OxidasesReactive Oxygen SpeciesReceptor for Advanced Glycation End Products

Identifiers

PMID27313835
PMCPMC4897723
OpenAlexW2406416032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.